Hand hygiene, the July effect, migraines and stroke, and more.
Researchers from the ROCKET AF trial, which was funded by Johnson & Johnson Pharmaceutical Research & Development and Bayer Healthcare, performed a prespecified secondary analysis to compare outcomes of rivaroxaban and warfarin treatment ... Past
Previous research has found that use of ICS in COPD patients reduced exacerbations but increased pneumonia, which made physicians hesitant to use them because they believed ICS must also increase mortality,
IVC filters and risk of death from pulmonary embolism, thrombolysis within two hours of stroke onset, and more.
Restrictive transfusions, hospice care use, and more.
The Institute for Safe Medication Practices (IMSP) Medication Safety Self-Assessment was first launched in 2000 in partnership with the American Hospital Association and the Health Research Educational Trust. ... The analysis was funded by the Agency for
The research was presented at the American Heart Association's Scientific Sessions and was published in the Dec.
Whether incorporating a depletive fluid management strategy into a bundle of preventive measures may favorably alter patients' outcomes needs further research.”.
The American Academy of Neurology recently issued a guideline update on preventing stroke in patients with nonvalvular atrial fibrillation (NVAF). ... The guideline update reviewed the evidence published since 1998, when the Academy's last guideline on
Reducing MRSA in the ICU, rivaroxaban in heart failure, warfarin bridging during cardiac device surgery, and more.